These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 19344007

  • 1. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD, Shpilberg O, Shaklai M, Bairey O.
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [Abstract] [Full Text] [Related]

  • 2. Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future.
    Chen J, Yang W, Gong Z.
    Ann Transl Med; 2018 Jun; 6(11):237. PubMed ID: 30023400
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of modified rituximab-ESHAP therapy for relapsed/refractory B-cell lymphoma.
    Ueda K, Nannya Y, Asai T, Yamamoto G, Hangaishi A, Takahashi T, Imai T, Kurokawa M.
    J Chemother; 2010 Feb; 22(1):54-7. PubMed ID: 20227994
    [Abstract] [Full Text] [Related]

  • 4. Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.
    Goel A, Spitz DR, Weiner GJ.
    J Cell Biochem; 2012 Feb; 113(2):419-25. PubMed ID: 21956712
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.
    Smith LK, Cidlowski JA.
    Prog Brain Res; 2010 Feb; 182():1-30. PubMed ID: 20541659
    [Abstract] [Full Text] [Related]

  • 6. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD, Shpilberg O, Shaklai M, Bairey O.
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [Abstract] [Full Text] [Related]

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 8. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 9. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 11. Ifosfamide in the treatment of lymphoma.
    Coiffier B.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):2-7. PubMed ID: 8711498
    [Abstract] [Full Text] [Related]

  • 12. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD, Shpilberg O, Shaklai M, Bairey O.
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [Abstract] [Full Text] [Related]

  • 13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 14. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 16. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].
    Fan Y, Huang ZY, Luo LH, Yu HF.
    Ai Zheng; 2008 Nov; 27(11):1222-5. PubMed ID: 19000458
    [Abstract] [Full Text] [Related]

  • 18. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD, Shpilberg O, Shaklai M, Bairey O.
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [Abstract] [Full Text] [Related]

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 20. Ifosfamide in the treatment of lymphoma.
    Coiffier B.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):2-7. PubMed ID: 8711498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.